1Tabarrini O, Cecchetti V, Fravolini A, et al.Design and synthesis of modified quinolones as antitumoral a - cridones[J ] .J Med Chem, 1999, 42:2 136.
2Kuo SC, Lee HZ, Juang JP, et al. Synthesis and cytotoxicity of 1, 6, 7, 8-substituted 2- (4' -substitued phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin[J] .J Med Chem, 1993,36(9):1 146.
3Xia Y, Yang ZY, Xia P, et al. Antitumor agents. 211. fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents[J ]. J Med Chem, 2001, 44:3 932.
4Kohlbrenner WE, Wideburg N, Weigl D, et al. Introducion of calf thymus topoisomerase II - mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A - 65282[J ]. Antimicrob. Agents Chemother, 1992, 36:81.
5Clement J J, Burres N,Jarvis K, et al. Biological characterization of a novel andtumor quinolone[J]. Cancer Res, 1995, 55(4) :830.
6Hammonds TR, Foster SR, Maxwell A. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase II [J ]. J Mol Biol,2000,300(3) :481.
7Elsea SH, Westergarrd M, Burden DA, et al. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage- enhancing antineoplastic drugs[J]. Biochemistry, 1997, 36(10) :2 919.
8Robinson MJ, Martin BA, Gootz TD, et al.Effect of quinolone derivatives on eukaryotic topoismerase II .Anovel mechanism for enhancement of enzyme- mediated DNA cleavage[J ]. J Biol Chem, 1991, 266(22) : 14 585.
9Kamat AM, Dehaven J I, Lamm DL. Quinolone antibiotics: a potential adjunce to intravesical chemotherapy for bladder cancer[J ]. Urology, 1999, 54(1) : 56.
10Engels EA, Lau J, Barza M, et al. Efficacy of quinolone prophylaxis in neutropenic cancer patients.a meta- analysis[J] .J Clin Oncol, 1998,16(3) :1179.
